SCHEMBL2014627

SCHEMBL2014627

CN(C(=O)c1cnc2sccn12)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.59
HCRTR2 O43614 2/20 0.59
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
NLRP3 Q96P20 1/20 0.38
HRH3 Q9Y5N1 2/20 0.38
HDAC6 Q9UBN7 2/20 0.37
TSHR P16473 1/20 0.37
PADI4 Q9UM07 2/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6918074 1.00 HCRTR1 (0.59) HCRTR1HCRTR2KDM4EALDH1A1HTT
SCHEMBL2014249 0.86 HCRTR1 (0.61) HCRTR1HCRTR2KDM4EALDH1A1NPC1
SCHEMBL2014646 0.85 HCRTR1 (0.56) HCRTR1HCRTR2NPC1RAB9ANLRP3
SCHEMBL2014124 0.84 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9ASMN1; SMN2
SCHEMBL2017397 0.82 HCRTR1 (0.57) HCRTR1HCRTR2ALDH1A1HTTNPC1
SCHEMBL13139060 0.82 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2012168 0.81 HCRTR1 (0.63) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2051297 0.80 HCRTR1 (0.62) HCRTR1HCRTR2NPC1RAB9ATP53
SCHEMBL2014992 0.80 HCRTR1 (0.62) HCRTR1HCRTR2NPC1RAB9ATP53
SCHEMBL2012310 0.80 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9AHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed